Young Li
Stock Analyst at Jefferies
(0.23)
# 4,180
Out of 4,876 analysts
5
Total ratings
33.33%
Success rate
-29.86%
Average return
Main Sectors:
Stocks Rated by Young Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RXST RxSight | Initiates: Buy | $72 | $12.67 | +468.27% | 1 | Oct 29, 2024 | |
| COO The Cooper Companies | Upgrades: Buy | $107 → $115 | $71.14 | +61.65% | 1 | Jul 16, 2024 | |
| HYPR Hyperfine | Initiates: Hold | $1.25 | $0.74 | +68.55% | 1 | Nov 30, 2023 | |
| ENOV Enovis | Initiates: Buy | $60 | $31.78 | +88.80% | 1 | Oct 12, 2022 | |
| ANIK Anika Therapeutics | Initiates: Neutral | $46 | $10.74 | +328.31% | 1 | Jul 16, 2021 |
RxSight
Oct 29, 2024
Initiates: Buy
Price Target: $72
Current: $12.67
Upside: +468.27%
The Cooper Companies
Jul 16, 2024
Upgrades: Buy
Price Target: $107 → $115
Current: $71.14
Upside: +61.65%
Hyperfine
Nov 30, 2023
Initiates: Hold
Price Target: $1.25
Current: $0.74
Upside: +68.55%
Enovis
Oct 12, 2022
Initiates: Buy
Price Target: $60
Current: $31.78
Upside: +88.80%
Anika Therapeutics
Jul 16, 2021
Initiates: Neutral
Price Target: $46
Current: $10.74
Upside: +328.31%